Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Articles published by Amicus Therapeutics, Inc. Amicus Therapeutics Announces Third Quarter 2024 Financial Results and Corporate Updates November 06, 2024 From Amicus Therapeutics, Inc. Via GlobeNewswire Tickers FOLD Amicus Therapeutics to Present at Upcoming Investor Conferences in November 2024 November 01, 2024 From Amicus Therapeutics, Inc. Via GlobeNewswire Tickers FOLD Amicus Therapeutics to Announce Third Quarter 2024 Financial Results on November 6, 2024 October 28, 2024 From Amicus Therapeutics, Inc. Via GlobeNewswire Tickers FOLD Amicus Therapeutics Announces Settlement of Galafold® (migalastat) Patent Litigation with Teva October 17, 2024 From Amicus Therapeutics, Inc. Via GlobeNewswire Tickers FOLD Amicus Therapeutics Announces Participation at the World Muscle Society Annual Congress 2024 October 04, 2024 From Amicus Therapeutics, Inc. Via GlobeNewswire Tickers FOLD UPDATE -- Amicus Therapeutics to Present at Upcoming Investor Conferences in September 2024 September 03, 2024 From Amicus Therapeutics, Inc. Via GlobeNewswire Tickers FOLD Amicus Therapeutics to Present at Upcoming Investor Conferences in September 2024 September 03, 2024 From Amicus Therapeutics, Inc. Via GlobeNewswire Tickers FOLD Amicus Therapeutics Announces Participation at the SSIEM 2024 Annual Symposium September 03, 2024 From Amicus Therapeutics, Inc. Via GlobeNewswire Tickers FOLD Amicus Therapeutics to Present at Upcoming Investor Conferences in September 2024 August 30, 2024 From Amicus Therapeutics, Inc. Via GlobeNewswire Tickers FOLD Amicus Therapeutics Announces Second Quarter 2024 Financial Results and Corporate Updates August 08, 2024 From Amicus Therapeutics, Inc. Via GlobeNewswire Tickers FOLD Amicus Therapeutics to Announce Second Quarter 2024 Financial Results on August 8, 2024 July 30, 2024 From Amicus Therapeutics, Inc. Via GlobeNewswire Tickers FOLD Amicus Therapeutics to Present at the Goldman Sachs 45th Annual Global Healthcare Conference June 05, 2024 From Amicus Therapeutics, Inc. Via GlobeNewswire Tickers FOLD Amicus Therapeutics Receives Prix Galien U.K. Award for Pombiliti® (cipaglucosidase alfa) + Opfolda® (miglustat) as Best Pharmaceutical Product June 04, 2024 From Amicus Therapeutics, Inc. Via GlobeNewswire Tickers FOLD Amicus Therapeutics Announces First Quarter 2024 Financial Results and Corporate Updates May 09, 2024 From Amicus Therapeutics, Inc. Via GlobeNewswire Tickers FOLD Amicus Therapeutics to Present at the Bank of America 2024 Health Care Conference May 08, 2024 From Amicus Therapeutics, Inc. Via GlobeNewswire Tickers FOLD Amicus Therapeutics to Announce First Quarter 2024 Financial Results on May 9, 2024 May 01, 2024 From Amicus Therapeutics, Inc. Via GlobeNewswire Tickers FOLD Amicus Therapeutics Issues 2024 Environmental, Social, and Governance (ESG) Report March 20, 2024 From Amicus Therapeutics, Inc. Via GlobeNewswire Tickers FOLD Amicus Therapeutics to Present at Upcoming Investor Conferences in March 2024 March 01, 2024 From Amicus Therapeutics, Inc. Via GlobeNewswire Tickers FOLD Amicus Therapeutics Announces Full-Year 2023 Financial Results and Corporate Updates February 28, 2024 From Amicus Therapeutics, Inc. Via GlobeNewswire Tickers FOLD Amicus Therapeutics to Announce Full Year 2023 Financial Results on February 28, 2024 February 15, 2024 From Amicus Therapeutics, Inc. Via GlobeNewswire Tickers FOLD Amicus Therapeutics Receives the 2024 New Treatment Award for Pombiliti™ (cipaglucosidase alfa-atga) + Opfolda™ (miglustat) at the 20th Annual WORLDSymposium™ February 08, 2024 From Amicus Therapeutics, Inc. Via GlobeNewswire Tickers FOLD Amicus Therapeutics Announces Presentations and Posters at the 20th Annual WORLDSymposium™ 2024 February 01, 2024 From Amicus Therapeutics, Inc. Via GlobeNewswire Tickers FOLD Amicus Therapeutics Reports Preliminary 2023 Revenue and Provides 2024 Strategic Outlook January 07, 2024 From Amicus Therapeutics, Inc. Via GlobeNewswire Tickers FOLD Amicus Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference January 03, 2024 From Amicus Therapeutics, Inc. Via GlobeNewswire Tickers FOLD Amicus Therapeutics Congratulates Executive Chairman John F. Crowley on Appointment as Next President and CEO of BIO December 05, 2023 From Amicus Therapeutics, Inc. Via GlobeNewswire Tickers FOLD Amicus Therapeutics Announces Third Quarter 2023 Financial Results and Corporate Updates November 08, 2023 From Amicus Therapeutics, Inc. Via GlobeNewswire Tickers FOLD Amicus Therapeutics to Present at Upcoming Investor Conferences in November 2023 November 01, 2023 From Amicus Therapeutics, Inc. Via GlobeNewswire Tickers FOLD Amicus Therapeutics to Announce Third Quarter 2023 Financial Results on November 8, 2023 October 27, 2023 From Amicus Therapeutics, Inc. Via GlobeNewswire Tickers FOLD Amicus Therapeutics Announces Presentation and Posters at World Muscle Society 2023 October 03, 2023 From Amicus Therapeutics, Inc. Via GlobeNewswire Tickers FOLD Amicus Therapeutics and Blackstone Enter into $430 Million Strategic Financing Collaboration October 02, 2023 From Amicus Therapeutics, Inc. Via GlobeNewswire Tickers FOLD Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
